Truvada News and Research

RSS
HHS hands out free HIV prevention drugs. Do you qualify?

HHS hands out free HIV prevention drugs. Do you qualify?

Research leverages emergency room visits to connect at risk populations to preventive services

Research leverages emergency room visits to connect at risk populations to preventive services

New California law may expand use of HIV prevention drugs, with caveats

New California law may expand use of HIV prevention drugs, with caveats

FDA keeps brand-name drugs on a fast path to market ― despite manufacturing concerns

FDA keeps brand-name drugs on a fast path to market ― despite manufacturing concerns

New protocol for HIV prevention drug reduces the number of pills required

New protocol for HIV prevention drug reduces the number of pills required

Vaginal ring used by most women for HIV prevention in open-label study

Vaginal ring used by most women for HIV prevention in open-label study

Tailored adherence strategies needed to engage young African women in consistent PrEP use

Tailored adherence strategies needed to engage young African women in consistent PrEP use

Even when HIV prevention drug is covered, other costs block treatment

Even when HIV prevention drug is covered, other costs block treatment

Trump plan to beat HIV hits rough road in rural America

Trump plan to beat HIV hits rough road in rural America

MTN launches new study to empower teen girls with choices in HIV prevention

MTN launches new study to empower teen girls with choices in HIV prevention

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

New simulation approach predicts efficacy of HIV-prophylaxis medications

New simulation approach predicts efficacy of HIV-prophylaxis medications

PrEP campaign aims to block HIV infection and save lives in D.C.

PrEP campaign aims to block HIV infection and save lives in D.C.

Use of HIV-prevention drug grows, but lags among non-whites

Use of HIV-prevention drug grows, but lags among non-whites

HIV pre-exposure prophylaxis (PrEP) could be cost saving for NHS in long run

HIV pre-exposure prophylaxis (PrEP) could be cost saving for NHS in long run

HIV prevention drug to be trialed by Britain's NHS

HIV prevention drug to be trialed by Britain's NHS

UTHealth participates in study to evaluate effectiveness of new injectable HIV medication

UTHealth participates in study to evaluate effectiveness of new injectable HIV medication

CDC guidelines for PrEP use to prevent HIV transmission do not go far enough, UCLA study suggests

CDC guidelines for PrEP use to prevent HIV transmission do not go far enough, UCLA study suggests

First large-scale clinical study of long-acting injectable HIV drug begins

First large-scale clinical study of long-acting injectable HIV drug begins

Study explores men's perceptions of new HIV prevention treatment

Study explores men's perceptions of new HIV prevention treatment